NO20030213D0 - Anvendelse av D2/D3 reseptor-agonister for behandling av fibromyalgi - Google Patents

Anvendelse av D2/D3 reseptor-agonister for behandling av fibromyalgi

Info

Publication number
NO20030213D0
NO20030213D0 NO20030213A NO20030213A NO20030213D0 NO 20030213 D0 NO20030213 D0 NO 20030213D0 NO 20030213 A NO20030213 A NO 20030213A NO 20030213 A NO20030213 A NO 20030213A NO 20030213 D0 NO20030213 D0 NO 20030213D0
Authority
NO
Norway
Prior art keywords
fibromyalgia
treatment
receptor agonists
agonists
receptor
Prior art date
Application number
NO20030213A
Other languages
English (en)
Other versions
NO20030213L (no
Inventor
Andrew J Holman
Original Assignee
Andrew J Holman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andrew J Holman filed Critical Andrew J Holman
Publication of NO20030213D0 publication Critical patent/NO20030213D0/no
Publication of NO20030213L publication Critical patent/NO20030213L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO20030213A 2000-07-17 2003-01-16 Anvendelse av D2/D3 reseptor-agonister for behandling av fibr omyalgi NO20030213L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/617,177 US6277875B1 (en) 2000-07-17 2000-07-17 Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
PCT/US2001/021530 WO2002005797A2 (en) 2000-07-17 2001-07-05 Use of dopamine d2/d3 receptor agonists to treat fibromyalgia

Publications (2)

Publication Number Publication Date
NO20030213D0 true NO20030213D0 (no) 2003-01-16
NO20030213L NO20030213L (no) 2003-03-11

Family

ID=24472575

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030213A NO20030213L (no) 2000-07-17 2003-01-16 Anvendelse av D2/D3 reseptor-agonister for behandling av fibr omyalgi

Country Status (17)

Country Link
US (2) US6277875B1 (no)
EP (1) EP1311251A2 (no)
JP (1) JP2004503587A (no)
KR (1) KR100797603B1 (no)
CN (1) CN1443066A (no)
AU (2) AU7191001A (no)
BR (1) BR0112476A (no)
CA (1) CA2414774C (no)
CZ (1) CZ2003417A3 (no)
HU (1) HUP0301305A3 (no)
IL (1) IL153915A0 (no)
MX (1) MXPA03000336A (no)
NO (1) NO20030213L (no)
NZ (1) NZ523926A (no)
PL (1) PL360121A1 (no)
WO (1) WO2002005797A2 (no)
ZA (1) ZA200300588B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1418099A (zh) * 2000-04-21 2003-05-14 法玛西雅厄普约翰美国公司 用于治疗肌纤维疼痛和慢性疲劳综合征的精选化合物
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
WO2002069974A1 (en) * 2001-03-05 2002-09-12 Andrew Holman Administration of sleep restorative agents
DE10137162A1 (de) * 2001-07-30 2003-02-20 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
GB0125088D0 (en) * 2001-10-18 2001-12-12 Smithkline Beecham Cork Ltd New use
US7079888B2 (en) * 2002-04-11 2006-07-18 Ansar, Inc. Method and apparatus for monitoring the autonomic nervous system using non-stationary spectral analysis of heart rate and respiratory activity
US20040048779A1 (en) * 2002-05-06 2004-03-11 Erwin Schollmayer Use of rotigotine for treating the restless leg syndrome
AR040680A1 (es) * 2002-07-25 2005-04-13 Pharmacia Corp Composicion de tabletas de liberacion sostenida
AR040682A1 (es) * 2002-07-25 2005-04-13 Pharmacia Corp Forma de dosificacion una vez al dia de pramipexol
US20050226926A1 (en) * 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
US20040092504A1 (en) * 2002-11-12 2004-05-13 Anuthep Benja-Athon Definitive medications for treating fibromyalgia
DE60204229T2 (de) * 2002-12-02 2006-02-02 Schwarz Pharma Ag Verabreichung von Rotigotine zur Behandlung der Parkinson'schen Krankheit durch Iontophorese
DE10334187A1 (de) * 2003-07-26 2005-03-03 Schwarz Pharma Ag Substituierte 2-Aminotetraline zur Behandlung von Depressionen
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
JP4785847B2 (ja) * 2004-08-13 2011-10-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング プラミペキソール又はその医薬品として許容される塩を含む放出が延長された錠剤調合物、その製造方法及びその使用
BRPI0513848A (pt) * 2004-08-13 2008-05-20 Boehringer Ingelheim Int formulação de pélete de liberação prolongada contendo pramipexol ou um sal farmaceuticamente aceitável deste, método para fabricação da mesma e uso desta
US20090325911A1 (en) * 2005-10-21 2009-12-31 Caritas St. Elizabeth Medical Center Of Boston, Inc. Use of Androgens for the Treatment of Parkinson's Disease
WO2007090881A2 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Modified release formulation
WO2007090883A1 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Extended release formulation
TWI392670B (zh) * 2006-06-22 2013-04-11 Ucb Pharma Gmbh 經取代的２-胺基萘滿之於製造用於預防、減緩及／或治療各種類型疼痛之藥物上的用途
CN1944647B (zh) * 2006-08-23 2010-05-12 华东师范大学 多巴胺受体新亚型d5b基因及编码的蛋白与应用
GB0700786D0 (en) * 2007-01-15 2007-02-21 Pfizer Ltd Morpholine dopamine agonists for the treatment of pain
EP1987815A1 (en) * 2007-05-04 2008-11-05 Schwarz Pharma Ag Oronasopharyngeally deliverable pharmaceutical compositions of dopamine agonists for the prevention and/or treatment of restless limb disorders
US20110195117A1 (en) * 2008-09-01 2011-08-11 Lupin Limited Controlled release compositions of ropinirole
EP2452677A1 (en) 2008-09-29 2012-05-16 Wockhardt Limited Extended release dosage form of ropinirole
WO2010044108A2 (en) 2008-10-17 2010-04-22 Rubicon Research Private Limited Controlled release formulations of ropinirole
KR20120137373A (ko) 2010-04-30 2012-12-20 테이코쿠 팔마 유에스에이, 인코포레이티드 프로필아미노인단 경피 조성물
JP5906302B2 (ja) 2011-03-24 2016-04-20 テイコク ファーマ ユーエスエー インコーポレーテッド 作用剤層および作用剤変換層を含む経皮組成物
WO2013070526A1 (en) 2011-11-09 2013-05-16 Teikoku Pharma Usa, Inc. Methods for the treatment of skin neoplasms
CN104797245B (zh) 2012-11-02 2018-05-04 帝国制药美国公司 丙炔基氨基茚满透皮组合物
MA41125A (fr) * 2014-12-05 2017-10-10 Purdue Pharma Lp Dérivés de 6.7-cyclomorphinane et leur utilisation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414224A (en) * 1980-08-22 1983-11-08 Smithkline Beckman Corporation Pharmaceutical composition and methods for producing dopamine agonist activity
US4879391A (en) * 1982-09-20 1989-11-07 Pfizer Inc. 1-Phenyl-2(1H,3H)-indolone psychotherapeutic agents
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
ATE45735T1 (de) * 1984-12-22 1989-09-15 Thomae Gmbh Dr K Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arnzneimittel.
DE3447075A1 (de) * 1984-12-22 1986-07-03 Dr. Karl Thomae Gmbh, 7950 Biberach Tetrahydro-benzthiazole, deren herstellung und deren verwendung als zwischenprodukte oder als arzneimittel
GB8712073D0 (en) * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
US5498610A (en) * 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives
US5696128A (en) 1994-07-07 1997-12-09 The Board Of Supervisors Of Louisiana University And Agricultural And Mechanical College Method of regulating immune function
US5658955A (en) 1994-11-01 1997-08-19 Hitzig; Pietr Combined use of dopamine and serotonin agonists in the treatment of immune disorders
CN1418099A (zh) * 2000-04-21 2003-05-14 法玛西雅厄普约翰美国公司 用于治疗肌纤维疼痛和慢性疲劳综合征的精选化合物

Also Published As

Publication number Publication date
PL360121A1 (en) 2004-09-06
US6277875B1 (en) 2001-08-21
CZ2003417A3 (cs) 2003-08-13
AU7191001A (en) 2002-01-30
WO2002005797A8 (en) 2003-03-06
CA2414774C (en) 2010-09-07
ZA200300588B (en) 2004-04-22
JP2004503587A (ja) 2004-02-05
AU2001271910B2 (en) 2005-07-28
US6300365B1 (en) 2001-10-09
IL153915A0 (en) 2003-07-31
CA2414774A1 (en) 2002-01-24
KR20030029625A (ko) 2003-04-14
NO20030213L (no) 2003-03-11
HUP0301305A3 (en) 2008-03-28
KR100797603B1 (ko) 2008-01-28
WO2002005797A2 (en) 2002-01-24
EP1311251A2 (en) 2003-05-21
NZ523926A (en) 2006-05-26
HUP0301305A2 (hu) 2003-08-28
CN1443066A (zh) 2003-09-17
MXPA03000336A (es) 2005-04-19
BR0112476A (pt) 2003-07-22

Similar Documents

Publication Publication Date Title
NO20030213D0 (no) Anvendelse av D2/D3 reseptor-agonister for behandling av fibromyalgi
NO20014379L (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
NO20032360D0 (no) EP4 reseptor selektive agonister for behandling av osteoporose
AR028253A1 (es) Inhibidores de la glucogeno fosforilasa
DE60125937D1 (de) Wirbelsäulenimplantat für osteosynthesevorrichtung
DK1446379T3 (da) Arylanilin-beta2-adrenergiske receptoragonister
FI20000863A (fi) Uusi hoitomenetelmä
BR0105828B1 (pt) dispositivo para locomoÇço de deficientes fÍsicos.
ATE305470T1 (de) Naphthyridinverbindungen
PT1206436E (pt) Retinoides para o tratamento de enfisema
HUP0401756A3 (en) Substituted benzimidazole compounds and their use
ES1044084Y (es) Dispositivo para la limpieza de fondos de piscinas.
PT1268482E (pt) Piranoindois para o tratamento de glaucoma
NO20005386D0 (no) Anvendelse av NMDA-antagonister for behandling av irritabel tarmsyndrom
NO20030717D0 (no) Forbindelser for behandling av avhengighetsforstyrrelser
PT1176991E (pt) Dispositivo ceramico para tratamento de feridas
DE60008489D1 (de) Lösbarer Endanschlag
ES1044076Y (es) Dispositivo para la limpieza de fondos de piscinas.
ID30381A (id) Penggunaan arilalkanoilpiridazina
NO20022142L (no) Anvendelse av dopamin-D3 reseptor agonister for behandling av saltavhengig hypertensjon
NO20014188L (no) Bremseanordning
FI20012104A0 (fi) Laitteisto kehon lämmittämiseksi
ES1050506Y (es) Dispositivo perfeccionado para la sujecion de sombrillas.
ES1054336Y (es) "ducha ortopedica para discapacitados"
FI20002756A0 (fi) Uusi hoitomenetelmä

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application